<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00989820</url>
  </required_header>
  <id_info>
    <org_study_id>NL20963.091.08</org_study_id>
    <nct_id>NCT00989820</nct_id>
  </id_info>
  <brief_title>Efficacy of Hyperbaric Oxygen Therapy in the Treatment of Osteoradionecrosis</brief_title>
  <official_title>Efficacy of Adding Hyperbaric Oxygen Therapy to the Treatment of Late Radiation Damage of the Lower Jaw (Osteoradionecrosis).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Radboud University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether hyperbaric oxygen therapy is effective in&#xD;
      the treatment of osteoradionecrosis (late damage after radiotherapy) of the jaw.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Late radiation damage to the lower jaw (osteoradionecrosis (ORN)) is often seen in patients&#xD;
      treated with radiotherapy for a tumor in the head and neck region. Part of the lower jaw&#xD;
      becomes non-vital and has to be treated. ORN proofs to be a condition difficult to treat and&#xD;
      the treatment for this condition varies.&#xD;
&#xD;
      In many countries hyperbaric oxygen therapy (HBOT) is added to the surgical treatment of ORN.&#xD;
      Unfortunately there is no consensus whether the addition of hyperbaric oxygen therapy to the&#xD;
      treatment of ORN is beneficial or not. This study has the aim to investigate the efficacy and&#xD;
      cost-effectiveness of HBOT in the treatment of ORN&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Recruitment problems, patients refused to participate&#xD;
  </why_stopped>
  <start_date type="Actual">October 2009</start_date>
  <completion_date type="Anticipated">May 1, 2018</completion_date>
  <primary_completion_date type="Actual">May 1, 2017</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>absence of exposed bone, fistulae or ulceration.</measure>
    <time_frame>12 months after finishing therapy in the arm assigned to</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain score</measure>
    <time_frame>one year after primairy therapy assigned to.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical and radiological assessment of the treatment response</measure>
    <time_frame>one year after initial therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Completion of the therapy in the arm for which patient has been randomized; if someone drops out of this study the reason will be scored.</measure>
    <time_frame>one year after initial therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of pain medication</measure>
    <time_frame>one year after initial therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Type of surgical intervention (sequestrectomy, marginal mandibula resection, segment resection)</measure>
    <time_frame>one year after initial therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>one year after initial therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost effectiveness</measure>
    <time_frame>one year after initial therapy</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Osteoradionecrosis</condition>
  <arm_group>
    <arm_group_label>Surgery</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This is the standard arm. Surgery without hyperbaric oxygen treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hyperbaric oxygen therapy with surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention arm. Hyperbaric oxygen therapy with surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>hyperbaric oxygen</intervention_name>
    <description>30 session inhalation of 100% oxygen in a pressure chamber under 2.4 ATA for 90 minutes a day before surgery and 10 session hyperbaric oxygen therapy (as mentioned before) after surgery</description>
    <arm_group_label>Hyperbaric oxygen therapy with surgery</arm_group_label>
    <other_name>Linde Gas Therapeutics Benelux B.V.</other_name>
    <other_name>RVG 30355</other_name>
    <other_name>ATC code V03AN012</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Informed consent&#xD;
&#xD;
          -  Age ≥ 18 jr&#xD;
&#xD;
          -  WHO performance status 0-2&#xD;
&#xD;
          -  Last radiation treatment ≥ 6 month ago radiotherapy with curative intention and &gt; 55&#xD;
             Gy. The affected part of the jaw must be in the target volume area of the radiotherapy&#xD;
             field.&#xD;
&#xD;
          -  Local recurrence must be ruled out&#xD;
&#xD;
          -  Necrosis of the jaw with at least one of the following symptoms for over 3 month&#xD;
             present:&#xD;
&#xD;
               -  Bone exposition which measures at least 1 cm&#xD;
&#xD;
               -  Evident bone lesions at radiologic evaluation (panorex) that fits the diagnosis&#xD;
                  ORN.&#xD;
&#xD;
               -  Non-healing extraction socket&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Former HBO treatment&#xD;
&#xD;
          -  Contra indication for HBO treatment (pneumothorax)&#xD;
&#xD;
          -  Bisphosphonate treatment in the medical history&#xD;
&#xD;
          -  reirradiation in the medical history&#xD;
&#xD;
          -  Osteosynthesis material in the affected area&#xD;
&#xD;
          -  Distant metastasis&#xD;
&#xD;
          -  Primary or recurrent tumor in the affected area&#xD;
&#xD;
          -  Malignancies elsewhere&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francois Dieleman, MD DMD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radboud University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thijs Merkx, MD DMD PhD</last_name>
    <role>Study Director</role>
    <affiliation>Radboud University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hans Kaanders, MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>Raboud University Medical Centre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>NKI/AvL</name>
      <address>
        <city>Amsterdam</city>
        <zip>1066CX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VU University Medical centre</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Center Groningen</name>
      <address>
        <city>Groningen</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leiden University Medical Center</name>
      <address>
        <city>Leiden</city>
        <zip>2333ZA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maastricht Universitary Medical Centre</name>
      <address>
        <city>Maastricht</city>
        <zip>6229HX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Radboud University Nijmegen Medical Centre</name>
      <address>
        <city>Nijmegen</city>
        <zip>6525GA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Erasmus University Medical Center</name>
      <address>
        <city>Rotterdam</city>
        <zip>3015CE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Center Utrecht</name>
      <address>
        <city>Utrecht</city>
        <zip>3584CX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <link>
    <url>http://www.nwhht.nl</url>
    <description>Dutch Co-operative Head and Neck Group</description>
  </link>
  <verification_date>April 2016</verification_date>
  <study_first_submitted>October 5, 2009</study_first_submitted>
  <study_first_submitted_qc>October 5, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 6, 2009</study_first_posted>
  <last_update_submitted>May 29, 2017</last_update_submitted>
  <last_update_submitted_qc>May 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>osteoradionecrosis</keyword>
  <keyword>mandible</keyword>
  <keyword>radiotherapy</keyword>
  <keyword>hyperbaric oxygen therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoradionecrosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coal Tar</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

